Plasma circulating tumor DNA in pancreatic adenocarcinoma for screening, diagnosis, prognosis, treatment and follow-up: A Systematic Review

Pancreatic adenocarcinoma (PA) is expected to be the 4th leading cause of cancer-related death, with 47 050 deaths projected to occur in 2020 in the United States [1]. Its 5-year survival rate is one of the worst in the field of oncology and is

Source: Cancer Treatment Reviews - May 3, 2020 Category: Cancer & Oncology Authors: Ra ëf Abdallah, Valérie Taly, Shulin Zhao, Daniel Pietrasz, Jean-Baptiste Bachet, Debora Basile, Léo Mas, Aziz Zaanan, Pierre Laurent-Puig, Julien Taieb Tags: Hot Topic Source Type: research